Annual report pursuant to section 13 and 15(d)

CONSOLIDATED STATEMENTS OF OPERATIONS

v2.4.0.8
CONSOLIDATED STATEMENTS OF OPERATIONS (USD $)
12 Months Ended 190 Months Ended
Dec. 31, 2013
Dec. 31, 2012
Dec. 31, 2011
Dec. 31, 2013
Income Statement [Abstract]        
Net sales $ 0 $ 0 $ 0 $ 69,000
Cost of goods sold 0 0 0 24,120
Gross profit 0 0 0 44,880
Operating expenses 11,883,975 7,187,170 6,698,181 62,954,280
Research and development expenses 2,011,486 963,184 1,318,783 10,681,167
Non-cash patent settlement cost 0 0 0 1,610,066
Loss before other income (expense) (13,895,461) (8,150,354) (8,016,964) (75,200,633)
Other income (expense)        
Other income (loss) (23,895) 24,723 48,000 192,800
Interest income 0 0 0 16,342
Interest and financing expense (260) (3,627,732) (5,084,253) (20,304,609)
Gain (loss) due to change in fair value of derivative liabilities (220,614) (4,023,094) 2,021,536 (2,115,507)
Gain on extinguishment of derivative liabilities 3,441,752 2,445,095 0 5,886,847
Costs of private placement 0 0 0 (1,640,715)
Costs to induce conversion of notes 0 0 0 (469,043)
Gain on disposition of equipment 41,923 0 0 27,497
Settlement of Debt Due Morale/ Matthews 0 0 0 (927,903)
Settlement of litigation and debt 346 239,775 175,934 1,505,143
Net loss before provision for income taxes (10,656,209) (13,091,587) (10,855,747) (93,029,781)
Provision for income taxes 800 800 800 9,082
Net loss $ (10,657,009) $ (13,092,387) $ (10,856,547) $ (93,038,863)
Net loss per common share, basic and diluted $ (0.07) $ (0.10) $ (0.10)  
Weighted average common shares outstanding, basic and diluted 160,958,284 128,667,391 104,103,109